Canadian Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Medicure

Market Cap: CA$11.1m

A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.

Entheon Biomedical

Market Cap: CA$1.5m

Operates as a biotechnology research and development company.

XORTX Therapeutics

Market Cap: CA$5.0m

A late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease.

Onco-Innovations

Market Cap: CA$75.1m

A pre-clinical stage biotechnology company, develops drug candidates for cancer treatments.

Restart Life Sciences

Market Cap: CA$2.0m

Through its subsidiaries, operates as a biotechnology company worldwide.

Vaxil Bio

Market Cap: CA$671.2k

A biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer.

High Tide

Market Cap: CA$254.1m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Cronos Group

Market Cap: CA$1.1b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

Innovotech

Market Cap: CA$13.9m

Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.

Thiogenesis Therapeutics

Market Cap: CA$32.3m

A clinical-stage biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs.

Medicenna Therapeutics

Market Cap: CA$86.7m

An immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases.

Devonian Health Group

Market Cap: CA$24.5m

Engages in the development of botanical drugs.

Avant Brands

Market Cap: CA$9.1m

Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.

Psyence Group

Market Cap: CA$1.2m

A life science biotechnology company, engages in the cultivation and production of commercial psilocybin mushroom.

BioSyent

Market Cap: CA$134.5m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

Steep Hill

Market Cap: CA$970.7k

Does not have significant operations.

1CM

Market Cap: CA$29.4m

Operates as a multi-jurisdictional cannabis company in Canada.

Bright Minds Biosciences

Market Cap: CA$278.1m

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Microbix Biosystems

Market Cap: CA$48.6m

A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.

Grown Rogue International

Market Cap: CA$119.2m

A craft cannabis company, focuses on premium flower and flower-derived products.

Cytophage Technologies

Market Cap: CA$10.2m

A biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada.

Captor Capital

Market Cap: CA$1.5m

Engages in the retail sale of cannabis products in the United States.

Covalon Technologies

Market Cap: CA$76.8m

Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.

Oncolytics Biotech

Market Cap: CA$49.7m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.

Rubicon Organics

Market Cap: CA$26.8m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

MediPharm Labs

Market Cap: CA$31.1m

Operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally.

NurExone Biologic

Market Cap: CA$52.3m

Operates as a pharmaceutical technology company.

BriaCell Therapeutics

Market Cap: CA$26.6m

A clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.

Satellos Bioscience

Market Cap: CA$121.2m

A biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.

Blueberries Medical

Market Cap: CA$7.4m

Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.

InnoCan Pharma

Market Cap: CA$46.8m

A pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally.

ME Therapeutics Holdings

Market Cap: CA$267.1m

A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.

Telo Genomics

Market Cap: CA$8.5m

A molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions primarily in Canada.

SOL Global Investments

Market Cap: CA$15.8m

A private equity firm specializing in growth capital to small and mid-sized businesses.

Crescita Therapeutics

Market Cap: CA$9.7m

A dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally.

Aurora Cannabis

Market Cap: CA$415.5m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.